Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rugang Zhang

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Expert Review of Precision Medicine and Drug Development|December 8, 2018
Epigenetic inhibitors for the precision treatment of <i>ARID1A</i>-mutant ovarian cancers: what are the next steps?Takeshi Fukumoto, Rugang Zhang, Benjamin G Bitler
American Journal of Physiology. Cell Physiology|May 14, 2004
Dibasic phosphorylation sites in the R domain of CFTR have stimulatory and inhibitory effects on channel activationHoria Vais, Rugang Zhang, William W Reenstra
International Journal of Cancer|January 5, 2002
Growth inhibition of BEL-7404 human hepatoma cells by expression of mutant telomerase reverse transcriptaseRugang Zhang, Xingwang Wang, Lixia Guo, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 18, 2002
[99mTc-Pingyangmycin imaging in the diagnosis of primary lung cancer]Liangze Zhang, Rugang Zhang, Dechao Zhang, et al.
Molecular & Cellular Oncology|June 17, 2016
Epigenetic synthetic lethality in ovarian clear cell carcinoma: EZH2 and ARID1A mutationsBenjamin G Bitler, Katherine M Aird, Rugang Zhang
Molecular & Cellular Oncology|May 12, 2020
<i>ARID1A</i> mutation and genomic stabilityTimothy Nacarelli, Bo Zhao, Xue Hao, et al.
Cancer Immunology, Immunotherapy : CII|May 22, 2020
Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitorsAyumi Hashimoto, Takeshi Fukumoto, Rugang Zhang, et al.
Cell Cycle (Georgetown, Tex.)|May 29, 2015
A novel role for the condensin II complex in cellular senescenceYuhki Yokoyama, Hengrui Zhu, Rugang Zhang, et al.
Molecular Cancer Research : MCR|December 1, 2010
Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cellsHua Li, Qi Cai, Andrew K Godwin, et al.
Molecular and Cellular Biology|February 27, 2013
BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 lossZhigang Tu, Xinying Zhuang, Yong-Gang Yao, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Expert Review of Precision Medicine and Drug Development|December 8, 2018
Epigenetic inhibitors for the precision treatment of <i>ARID1A</i>-mutant ovarian cancers: what are the next steps?Takeshi Fukumoto, Rugang Zhang, Benjamin G Bitler
American Journal of Physiology. Cell Physiology|May 14, 2004
Dibasic phosphorylation sites in the R domain of CFTR have stimulatory and inhibitory effects on channel activationHoria Vais, Rugang Zhang, William W Reenstra
International Journal of Cancer|January 5, 2002
Growth inhibition of BEL-7404 human hepatoma cells by expression of mutant telomerase reverse transcriptaseRugang Zhang, Xingwang Wang, Lixia Guo, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 18, 2002
[99mTc-Pingyangmycin imaging in the diagnosis of primary lung cancer]Liangze Zhang, Rugang Zhang, Dechao Zhang, et al.
Molecular & Cellular Oncology|June 17, 2016
Epigenetic synthetic lethality in ovarian clear cell carcinoma: EZH2 and ARID1A mutationsBenjamin G Bitler, Katherine M Aird, Rugang Zhang
Molecular & Cellular Oncology|May 12, 2020
<i>ARID1A</i> mutation and genomic stabilityTimothy Nacarelli, Bo Zhao, Xue Hao, et al.
Cancer Immunology, Immunotherapy : CII|May 22, 2020
Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitorsAyumi Hashimoto, Takeshi Fukumoto, Rugang Zhang, et al.
Cell Cycle (Georgetown, Tex.)|May 29, 2015
A novel role for the condensin II complex in cellular senescenceYuhki Yokoyama, Hengrui Zhu, Rugang Zhang, et al.
Molecular Cancer Research : MCR|December 1, 2010
Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cellsHua Li, Qi Cai, Andrew K Godwin, et al.
Molecular and Cellular Biology|February 27, 2013
BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 lossZhigang Tu, Xinying Zhuang, Yong-Gang Yao, et al.
Pageof 15